Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund-Wistar rats

Julie E. Heinrich, Morris Pollard, William A. Wolter, Zhong Liang, Hui Song, Elliot Rosen, Mark A. Suckow

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Reducing expression of the tissue factor gene in prostate adenocarcinoma cells (PAIII) results in a cell line that, in vivo, mimics the growth of wildtype (wt) PAIII. However, instead of continuing to grow and metastasize as wt PAIII tumors do, tissue factor deficient PAIII (TFD PAIII) masses spontaneously regress after several weeks. Although whole cell vaccines are typically inactivated prior to administration to prevent proliferation within the host, numerous studies have suggested that exposure to live, attenuated, whole tumor cells, and the extracellular microenvironment they recruit, increases immunotherapeutic potential. Here, we provide support for this notion, and a strategy through which to implement it, by demonstrating that subcutaneous vaccinations with the TFD PAIII protect the Lobund-Wistar rat against subsequent wt PAIII cell challenge. TFD PAIII immunized rats suffered significantly less metastasis of wt PAIII challenge tumors compared to unvaccinated naïve controls rats. These results offer the intriguing possibility that the TFD PAIII vaccine is an effective system for the prevention and, possibly, the treatment of prostate cancer.

Original languageEnglish
Pages (from-to)725-730
Number of pages6
JournalCancer Immunology Immunotherapy
Volume56
Issue number5
DOIs
StatePublished - May 2007

Fingerprint

Thromboplastin
Wistar Rats
Prostatic Neoplasms
Vaccination
Cell Line
Cellular Microenvironment
Neoplasms
Inactivated Vaccines
Prostate
Adenocarcinoma
Vaccines
Neoplasm Metastasis
Growth
Genes

Keywords

  • Metastasis
  • Prostate cancer
  • Stroma
  • Tissue factor
  • Vaccine
  • Whole-tumor cell

ASJC Scopus subject areas

  • Cancer Research
  • Immunology
  • Oncology

Cite this

Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund-Wistar rats. / Heinrich, Julie E.; Pollard, Morris; Wolter, William A.; Liang, Zhong; Song, Hui; Rosen, Elliot; Suckow, Mark A.

In: Cancer Immunology Immunotherapy, Vol. 56, No. 5, 05.2007, p. 725-730.

Research output: Contribution to journalArticle

Heinrich, Julie E. ; Pollard, Morris ; Wolter, William A. ; Liang, Zhong ; Song, Hui ; Rosen, Elliot ; Suckow, Mark A. / Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund-Wistar rats. In: Cancer Immunology Immunotherapy. 2007 ; Vol. 56, No. 5. pp. 725-730.
@article{fc12b1ab12e74711bc408b1356768f97,
title = "Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund-Wistar rats",
abstract = "Reducing expression of the tissue factor gene in prostate adenocarcinoma cells (PAIII) results in a cell line that, in vivo, mimics the growth of wildtype (wt) PAIII. However, instead of continuing to grow and metastasize as wt PAIII tumors do, tissue factor deficient PAIII (TFD PAIII) masses spontaneously regress after several weeks. Although whole cell vaccines are typically inactivated prior to administration to prevent proliferation within the host, numerous studies have suggested that exposure to live, attenuated, whole tumor cells, and the extracellular microenvironment they recruit, increases immunotherapeutic potential. Here, we provide support for this notion, and a strategy through which to implement it, by demonstrating that subcutaneous vaccinations with the TFD PAIII protect the Lobund-Wistar rat against subsequent wt PAIII cell challenge. TFD PAIII immunized rats suffered significantly less metastasis of wt PAIII challenge tumors compared to unvaccinated na{\"i}ve controls rats. These results offer the intriguing possibility that the TFD PAIII vaccine is an effective system for the prevention and, possibly, the treatment of prostate cancer.",
keywords = "Metastasis, Prostate cancer, Stroma, Tissue factor, Vaccine, Whole-tumor cell",
author = "Heinrich, {Julie E.} and Morris Pollard and Wolter, {William A.} and Zhong Liang and Hui Song and Elliot Rosen and Suckow, {Mark A.}",
year = "2007",
month = "5",
doi = "10.1007/s00262-006-0223-x",
language = "English",
volume = "56",
pages = "725--730",
journal = "Cancer Immunology, Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "5",

}

TY - JOUR

T1 - Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund-Wistar rats

AU - Heinrich, Julie E.

AU - Pollard, Morris

AU - Wolter, William A.

AU - Liang, Zhong

AU - Song, Hui

AU - Rosen, Elliot

AU - Suckow, Mark A.

PY - 2007/5

Y1 - 2007/5

N2 - Reducing expression of the tissue factor gene in prostate adenocarcinoma cells (PAIII) results in a cell line that, in vivo, mimics the growth of wildtype (wt) PAIII. However, instead of continuing to grow and metastasize as wt PAIII tumors do, tissue factor deficient PAIII (TFD PAIII) masses spontaneously regress after several weeks. Although whole cell vaccines are typically inactivated prior to administration to prevent proliferation within the host, numerous studies have suggested that exposure to live, attenuated, whole tumor cells, and the extracellular microenvironment they recruit, increases immunotherapeutic potential. Here, we provide support for this notion, and a strategy through which to implement it, by demonstrating that subcutaneous vaccinations with the TFD PAIII protect the Lobund-Wistar rat against subsequent wt PAIII cell challenge. TFD PAIII immunized rats suffered significantly less metastasis of wt PAIII challenge tumors compared to unvaccinated naïve controls rats. These results offer the intriguing possibility that the TFD PAIII vaccine is an effective system for the prevention and, possibly, the treatment of prostate cancer.

AB - Reducing expression of the tissue factor gene in prostate adenocarcinoma cells (PAIII) results in a cell line that, in vivo, mimics the growth of wildtype (wt) PAIII. However, instead of continuing to grow and metastasize as wt PAIII tumors do, tissue factor deficient PAIII (TFD PAIII) masses spontaneously regress after several weeks. Although whole cell vaccines are typically inactivated prior to administration to prevent proliferation within the host, numerous studies have suggested that exposure to live, attenuated, whole tumor cells, and the extracellular microenvironment they recruit, increases immunotherapeutic potential. Here, we provide support for this notion, and a strategy through which to implement it, by demonstrating that subcutaneous vaccinations with the TFD PAIII protect the Lobund-Wistar rat against subsequent wt PAIII cell challenge. TFD PAIII immunized rats suffered significantly less metastasis of wt PAIII challenge tumors compared to unvaccinated naïve controls rats. These results offer the intriguing possibility that the TFD PAIII vaccine is an effective system for the prevention and, possibly, the treatment of prostate cancer.

KW - Metastasis

KW - Prostate cancer

KW - Stroma

KW - Tissue factor

KW - Vaccine

KW - Whole-tumor cell

UR - http://www.scopus.com/inward/record.url?scp=33847384565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847384565&partnerID=8YFLogxK

U2 - 10.1007/s00262-006-0223-x

DO - 10.1007/s00262-006-0223-x

M3 - Article

C2 - 16953436

AN - SCOPUS:33847384565

VL - 56

SP - 725

EP - 730

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

SN - 0340-7004

IS - 5

ER -